A touching case of channel regulation: the ATP-sensitive K+ channel

https://doi.org/10.1016/S0959-4388(98)80055-XGet rights and content

Abstract

The classical type of KATP channel is an octameric (4:4) complex of two structurally unrelated subunits, Kir6.2 and SUR. The former serves as an ATP-inhibitable pore, while SUR is a regulatory subunit endowing sensitivity to sulphonylurea and K+ channel opener drugs, and the potentiatory action of MgADP. Both subunits are required to form a functional channel.

References (48)

  • QuayleJM et al.

    ATP-sensitive and inwardly-rectifying potassium channels in smooth muscle

    Physiol Rev

    (1997)
  • EdwardsG et al.

    The pharmacology of ATP-sensitive potassium channels

    Annu Rev Pharm Toxicol

    (1993)
  • Aguilar-BryanL et al.

    Cloning of the β-cell high-affinity sulphonylurea receptor: a regulator of insulin secretion

    Science

    (1995)
  • HigginsC

    ABC transporter: from microorganisms to man

    Annu Rev Cell Biol

    (1992)
  • InagakiN et al.

    Reconstitution of IKATP: an inward rectifier subunit plus the sulphonylurea receptor

    Science

    (1995)
  • GribbleFM et al.

    Properties of cloned ATP-sensitive K-currents expresed in Xenopus oocytes

    J Physiol

    (1997)
  • ChutkowWA et al.

    Cloning, tissue expression,and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels

    Diabetes

    (1996)
  • IsomotoS et al.

    A novel sulphonylurea receptor forms with BIR (Kir6.2) a smooth muscle type of ATP-sensitive K+ channel

    J Biol Chem

    (1996)
  • LissB et al.

    Single cell RT-PCR detection of ATP-sensitive potassium channel subunits: a heterogeneous expression pattern in dopaminergic neurons

    Pflügers Arch

    (1997)
  • KarschinC et al.

    Overlapping tissue distribution of KATP channel-forming Kir6.2 subunit and the sulphonylurea receptor SUR1 in rodent brain

    FEBS Lett

    (1996)
  • AshfordMLJ et al.

    Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels

    Pflügers Arch

    (1990)
  • AshfordMLJ et al.

    Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels

    Br J Pharmacol

    (1990)
  • YamadaYM et al.

    Sulphonylurea receptor SUR2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel

    J Physiol

    (1997)
  • ÄmmäläC et al.

    The sulphonylurea receptor confers diazoxide sensitivity on the inwardly-rectifyng K-channel, Kir6.1.

    J Physiol

    (1996)
  • Cited by (42)

    • ATP sensitive potassium channel openers: A new class of ocular hypotensive agents

      2017, Experimental Eye Research
      Citation Excerpt :

      SUR2A and SUR2B are identical except for the terminal 42 amino acid residues (Fig. 1B). ( Aguilar-Bryan et al., 1998) Both SUR1 and SUR2 are members of the ATP binding cassette (ABC) transporter superfamily, a common membrane protein found in all species that use energy from ATP hydrolysis to selectively translocate specific molecules across the cell membrane (Higgins and Linton, 2001; Tucker and Ashcroft, 1998). Similar to other ABC proteins, the SUR subunits contain two nuclear binding domains and two consensus nucleotide binding motifs (Conti et al., 2001).

    • Oleate induces K<inf>ATP</inf> channel-dependent hyperpolarization in mouse hypothalamic glucose-excited neurons without altering cellular energy charge

      2017, Neuroscience
      Citation Excerpt :

      Previously it has been suggested that oleate may inhibit ATP-dependent gating of an acetylcholine-modulated potassium channel (Kim and Pleumsamran, 2000). As KATP channel activity is controlled to a large extent by the ATP/ADP ratio in cells, with ATP-inhibiting and ADP-activating KATP activity, respectively (Tucker and Ashcroft, 1998), a simple explanation for the oleate-mediated hyperpolarization could be reduced ATP-dependent inhibition of channel activity. To examine this possibility, we first decided to replace ATP with the non-hydrolyzable ATP analog, 5′-adenylylimidodiphosphate (AMP-PNP; 3 mM) in the pipette solution.

    • Kir

      2007, xPharm: The Comprehensive Pharmacology Reference
    View all citing articles on Scopus
    View full text